Dysport

Dysport is a recent introduction to the cosmetic industry's line of injectable treatments, which was developed and introduced as a competitor to Botox, an injectable used to treat certain wrinkles which occur as a result of muscle movement.

Like Botox, Dysport is derived from botulinum toxin, and is used to treat so-called “dynamic” wrinkles, which occur as a result of facial movement, such as frowning or squinting. These wrinkles can be much more difficult to treat than “static” wrinkles, which occur when skin begins to sag with age. Common examples of dynamic wrinkles are frown lines, worry lines, crow's feet, bunny lines, marinette lines.

Dysport was first developed in the United Kingdom in the 1990s as a treatment for certain neuromuscular disorders, and has been used in more than 60 countries for treatment of various conditions and disorders. The U.S. Food and Drug Agency approved Dysport for cosmetic use in the United States in May 2009.

The initial results of Dysport are visible in 4 days after injection (compared to 7 days for botox) and last up to 4 months.